EP4580614A1 - Zusammensetzung zur pflege keratinischer materialien und maske damit - Google Patents

Zusammensetzung zur pflege keratinischer materialien und maske damit

Info

Publication number
EP4580614A1
EP4580614A1 EP22956878.7A EP22956878A EP4580614A1 EP 4580614 A1 EP4580614 A1 EP 4580614A1 EP 22956878 A EP22956878 A EP 22956878A EP 4580614 A1 EP4580614 A1 EP 4580614A1
Authority
EP
European Patent Office
Prior art keywords
composition
ascorbyl
mask
hydroxyhydrocinnamate
alginate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22956878.7A
Other languages
English (en)
French (fr)
Inventor
Libing CAI
Liang Zhang
Zhenxi LEE
Bingxiang LIU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of EP4580614A1 publication Critical patent/EP4580614A1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212Face masks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/733Alginic acid; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Definitions

  • Skin aging is part of the aging process of human body, which not only relates to the age itself, but also closely relates to external factors, such as sunlight exposure.
  • the light induced skin aging ( “light-aging” ) is mainly caused by sunlight irradiation, and as depletion of the ozone layer is aggravating, the light-aging of the skin becomes more and more serious, which affects the appearance of the skin.
  • lipophilic active ingredient such as retinoids cannot be delivered into the skin effectively.
  • the present invention provides a composition for caring for keratin materials, comprising:
  • the present invention provides a mask for caring for keratin materials, comprising:
  • the present invention also provides a non-therapeutic process for caring for keratin materials, in particular the skin, comprising the step of applying the composition or the mask according to the present invention on the keratin materials.
  • retinoids are stable for a relatively long term and can be delivered into the skin effectively.
  • keratin material is intended to cover the skin. Facial skin and eye skin are most particularly considered according to the present invention.
  • stable means that retinol or its derivatives contained in the mask will not decompose substantially for at least 2 months.
  • composition for caring for keratin materials comprises:
  • the composition according to the present invention comprises at least one retinoid.
  • the retinoids according to the present invention include retinol (vitamin A) , retinal (vitamin A aldehyde) , retinoic acid (vitamin A acid) , or an ester of retinol and of a C 2 -C 20 acid, such as the propionate, the acetate, the linoleate or the palmitate of retinol (retinyl palmitate) , among others.
  • the retinoid is selected from retinol, retinal, retinoic acid, esters of retinol and of a C 2 -C 20 acid, and a combination thereof.
  • retinoids mention may more particularly be made of retinol, retinal, retinoic acid, in particular all-trans retinoic acid and 13-cis retinoic acid, retinol derivatives, such as retinyl acetate, propionate or palmitate, and the retinoids described in the following patent applications: FR 2 370 377, EP 0 199 636, EP 0 325 540 and EP 0 402 072.
  • the retinoid is retinol or a pro-retinol.
  • retinol is intended to mean all the isomers of retinol, i.e. all-trans retinol, 13-cis retinol, 11-cis retinol, 9-cis retinol and 3, 4-didehydro retinol.
  • retinyl palmitate the palmitate of retinol
  • the retinoid is selected from retinol, retinyl palmitate, and a combination thereof.
  • the composition according to the present invention comprises retinol and/or retinyl palmitate.
  • the retinoid is present in an amount ranging from 0.1 wt.%to 5 wt. %, preferably from 0.1 wt. %to 2 wt. %, more preferably from 0.15 wt. %to 1 wt. %, relative to the total weight of the composition.
  • composition according to the present invention an antioxidant combination of i) ascorbic acid or its derivative, ii) tocopherol or its derivative, and iii) at least one hydroxyhydrocinnamate antioxidant.
  • derivatives of ascorbic acid include aminopropyl ascorbyl phosphate, ascorbic acid polypeptide, ascorbyl dipalmitate, ascorbyl glucoside, ascorbyl linoleate, ascorbyl methylsilanol pectinate, ascorbyl palmitate, ascorbyl tetraisopalmitate, trisodium ascorbyl palmitate phosphate, disodium ascorbyl sulfate, calcium ascorbate, methylsilanol ascorbate, sodium ascorbate, sodium ascorbyl phosphate, sodium ascorbyl/cholesteryl phosphate, tetrahexyldecyl ascorbate, magnesium ascorbyl phosphate, among others.
  • the composition according to the present invention comprises one or more of ascorbic acid, aminopropyl ascorbyl phosphate, ascorbic acid polypeptide, ascorbyl dipalmitate, ascorbyl glucoside, ascorbyl linoleate, ascorbyl methylsilanol pectinate, ascorbyl palmitate, ascorbyl tetraisopalmitate, trisodium ascorbyl palmitate phosphate, disodium ascorbyl sulfate, calcium ascorbate, methylsilanol ascorbate, sodium ascorbate, sodium ascorbyl phosphate, sodium ascorbyl/cholesteryl phosphate, tetrahexyldecyl ascorbate, magnesium ascorbyl phosphate.
  • the composition according to the present invention comprises ascorbic acid and/or ascorbyl glucoside.
  • ascorbic acid or its derivative is present in an amount ranging from 0.05 wt. %to 3 wt. %, preferably from 0.1 wt. %to 2 wt. %, more preferably from 0.15 wt. %to 1 wt. %, relative to the total weight of the composition.
  • derivatives of tocopherol include tocopheryl acetate, tocopheryl linoleate, tocopheryl linoleate/oleate, tocopheryl nicotinate, tocopheryl retinoate, sodium tocopheryl phosphate, dioleyl tocopheryl methylsilanol, among others.
  • the composition according to the present invention comprises one or more of tocopherol, tocopheryl acetate, tocopheryl linoleate, tocopheryl linoleate/oleate, tocopheryl nicotinate, tocopheryl retinoate, sodium tocopheryl phosphate, and dioleyl tocopheryl methylsilanol.
  • composition according to the present invention comprises tocopherol.
  • tocopherol or its derivative is present in an amount ranging from 0.05 wt. %to 3 wt. %, preferably from 0.1 wt. %to 2 wt. %, more preferably from 0.15 wt. %to 1 wt. %, relative to the total weight of the composition.
  • the hydroxyhydrocinnamate antioxidant is selected from pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, octadecyl di-t-butyl-4-hydroxyhydrocinnamate, tetradibutyl pentaerithrityl hydroxylhydrocinnamate, and a combination thereof.
  • the hydroxyhydrocinnamate antioxidant is present in an amount ranging from 0.05 wt. %to 3 wt. %, preferably from 0.1 wt. %to 2 wt.%, more preferably from 0.15 wt. %to 1 wt. %, relative to the total weight of the composition.
  • composition of the present invention may comprise an aqueous phase.
  • Said aqueous phase comprises water.
  • the aqueous phase comprises an organic solvent miscible with water (at room temperature 25°C) selected from glycols and polyols having from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, and preferentially having from 2 to 6 carbon atoms, such as glycerin, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, caprylyl glycol, dipropylene glycol, diethylene glycol; and combinations thereof, so as to provide a hydration effect.
  • an organic solvent miscible with water selected from glycols and polyols having from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, and preferentially having from 2 to 6 carbon atoms, such as glycerin, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, caprylyl glycol, dipropylene glycol, diethylene glycol; and combinations thereof, so as to provide
  • the aqueous phase is present in the composition of the present invention in an amount ranging from 50%to 95%by weight, preferably from 60%to 85%by weight, relative to the total weight of the composition.
  • composition of the present invention may comprise an oily phase.
  • Said oily phase comprise at least one oil.
  • the oil can be volatile or non-volatile.
  • oil means a water-immiscible non-aqueous compound that is liquid at room temperature (25°C) and at atmospheric pressure (760 mmHg) .
  • non-volatile oil means an oil that may remain on keratin materials at room temperature and atmospheric pressure for at least several hours and that especially has a vapour pressure of less than 10 -3 mmHg (0.13 Pa) .
  • a non-volatile oil may also be defined as having an evaporation rate such that, under the conditions defined previously, the amount evaporated after 30 minutes is less than 0.07 mg/cm 2 .
  • oils may be of plant, mineral or synthetic origin.
  • Said oil can be selected from hydrocarbon-based, silicone or fluorinated oils.
  • hydrocarbon-based oil means an oil formed essentially from, or even constituted by, carbon and hydrogen atoms, and optionally O and N atoms, and free of Si and F heteroatoms. Such oil can contain alcohol, ester, ether, carboxylic acid, amine and/or amide groups.
  • silicon oil means an oil containing at least one silicon atom, especially containing Si-O groups.
  • fluorinated oil means an oil containing at least one fluorine atom.
  • the oil is selected from hydrocarbon-based oils.
  • the oily phase is present in the composition of the present invention in an amount ranging from 1 wt. %to 20 wt. %, preferably from 2 wt. %to 10 wt. %, relative to the total weight of the composition of the present invention.
  • composition according to the present invention can comprises one or more additional cosmetic active ingredients.
  • enzymes for example, enzymes; flavonoids; humetants (for example, biosaccharide gum-1, mannose, sodium hyaluronate) ; tensioning agents; soothing agents; among others.
  • composition of the present invention may comprise conventional cosmetic adjuvants or additives, for instance, fragrances, surfactants (for example, non-ionic surfactants) , chelating agents (for example, trisodium ethylenediamine disuccinate) , preserving agents (for example, chlorphenesin and phenoxyethanol) and bactericides (for example, hydroxyacetophenone) , thickeners (for example, xanthan gum, ammonium polyacryloyldimethyl taurate) , pH adjusting agents (for example, sodium citrate) , and combinations thereof.
  • fragrances for instance, fragrances, surfactants (for example, non-ionic surfactants) , chelating agents (for example, trisodium ethylenediamine disuccinate) , preserving agents (for example, chlorphenesin and phenoxyethanol) and bactericides (for example, hydroxyacetophenone) , thickeners (for example, xanthan gum, ammonium polyacryloyld
  • the present invention provides a composition for caring for keratin materials comprising, relative to the total weight of the composition:
  • hydroxyhydrocinnamate antioxidant selected from pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, octadecyl di-t-butyl-4-hydroxyhydrocinnamate, tetradibutyl pentaerithrityl hydroxylhydrocinnamate, and a combination thereof.
  • composition of the present invention may be in the form of gel, lotion, or emulsion.
  • composition according to the present invention can be impregnated into a mask tissue to form a mask.
  • the present invention relates to a mask for caring for keratin materials, comprising:
  • the mask according to the present invention comprises a hydrophilic mask tissue.
  • the mask tissue is water-insoluble.
  • water-insoluble means that the mask tissue is not dissolvable in water and it doesn’ t break apart upon immersion in water.
  • the skilled in the art can choose a suitable mask tissue and the weight ratio of the mask tissue used and the composition according to the present invention based on the nature of the composition.
  • Alginate tissues are known in the art and are described in WO2020001069A1.
  • an alginate tissue may comprise a water-insoluble alginate chosen from calcium alginate, strontium alginate, zinc alginate, copper alginate, manganese alginate, or a combination thereof, preferably calcium alginate, preferably in an amount ranging from 20 wt. %to 100 wt. %, relative to the total weight of the tissue.
  • the composition according to the present invention comprises a pH adjusting agent selected from sodium acetate, sodium citrate, sodium tartrate, and a combination thereof in an amount ranging from 0.01 wt. %to 1.0 wt. %, preferably from 0.05 wt. %to 0.45 wt. %, more preferably from 0.15 wt. %to 0.3 wt. %, relative to the total weight of the composition according to the present invention.
  • a pH adjusting agent selected from sodium acetate, sodium citrate, sodium tartrate, and a combination thereof in an amount ranging from 0.01 wt. %to 1.0 wt. %, preferably from 0.05 wt. %to 0.45 wt. %, more preferably from 0.15 wt. %to 0.3 wt. %, relative to the total weight of the composition according to the present invention.
  • the mask tissue can have a wide variety of shapes, depending on the desired use and characteristic of the mask.
  • the mask tissue is typically designed to fit the area of the skin to which topical application is desired.
  • the mask tissue is designed to correspond to the shape of the face avoiding the eye, nostril, and mouth areas, as necessary.
  • the weight ratio of the water insoluble substrate and the composition ranges from 1: 3 to 1: 20. More preferably, the weight ratio of the water insoluble substrate and the composition ranges from 1: 10 to 1: 18.
  • composition or mask according to the present invention is intended for topical application and can especially be used for caring for keratin materials, and especially the skin.
  • composition according to the present invention can be used for anti-wrinkling.
  • the present invention provides a non-therapeutic process for caring for keratin materials, in particular the skin, comprising the step of applying the composition or the mask as defined above on the keratin materials.
  • the keratin materials are facial skin and/or eye skin.
  • the present invention provides a non-therapeutic process for caring for keratin materials, in particular skin, comprising:
  • compositions according to invention example (IE. ) 1 and comparative examples (CE. ) 1-4 were prepared with the ingredients listed in Table 2 (the contents are expressed as weight percentages of active material with regard to the total weight of each composition, unless otherwise indicated) :
  • Composition of invention example 1 represents composition according to the present invention.
  • Composition of comparative example 1 does not comprise an antioxidant.
  • Composition of comparative example 2 does not comprise ascorbic acid or its derivative.
  • Composition of comparative example 3 does not comprise ascorbic acid or its derivative, and hydroxyhydrocinnamate antioxidant.
  • invention example (IE. ) 4 20 g of the composition in Table 4 was impregnated into a tissue comprising 100 wt. %of alginate fiber derived from seaweed relative to the total weight of the tissue for 12 hours, wherein the weight ratio of the tissue and the composition is 1: 13.5. Then the procedure of invention example 2 was followed to determine the content of retinyl palmitate in the composition squeezed out.
  • comparative example (CE. ) 5 20 g of the composition in Table 4 was impregnated into a tissue made of viscose fiber, wherein the weight ratio of the water insoluble substrate and the composition is 1: 13.5. Then the procedure of invention example 2 was followed to determine the content of retinyl palmitate in the composition squeezed out.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
EP22956878.7A 2022-08-31 2022-08-31 Zusammensetzung zur pflege keratinischer materialien und maske damit Pending EP4580614A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2022/116226 WO2024045049A1 (en) 2022-08-31 2022-08-31 Composition for caring for keratin materials and mask containing the same

Publications (1)

Publication Number Publication Date
EP4580614A1 true EP4580614A1 (de) 2025-07-09

Family

ID=90014927

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22956878.7A Pending EP4580614A1 (de) 2022-08-31 2022-08-31 Zusammensetzung zur pflege keratinischer materialien und maske damit

Country Status (4)

Country Link
EP (1) EP4580614A1 (de)
CN (1) CN119654146A (de)
FR (1) FR3139006A1 (de)
WO (1) WO2024045049A1 (de)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2650851A1 (de) 1976-11-06 1978-05-11 Bosch Gmbh Robert Stromversorgungseinrichtung fuer eine zweispannungsanlage in einem kraftfahrzeug
LU85849A1 (fr) 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
LU87109A1 (fr) 1988-01-20 1989-08-30 Cird Esters et thioesters aromatiques,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
JPH03119163A (ja) 1989-06-05 1991-05-21 Sequa Chemicals Inc 不織繊維用バインダー
US20140271879A1 (en) * 2013-03-15 2014-09-18 Laboratory Skin Care, Inc. Fine dry particulate retinoid active agent compositions and topical formulations including the same
WO2017180440A1 (en) * 2016-04-11 2017-10-19 Amcol International Corporation Delivery system based on a natural microparticle for use in personal care and other topical applications
CN108456995B (zh) * 2018-01-22 2021-03-19 潍坊广栗新材料科技有限公司 一种高吸水性无纺布
CN112334124A (zh) * 2018-06-28 2021-02-05 莱雅公司 用于护理皮肤的套盒
CN113226248B (zh) * 2018-11-05 2025-04-08 莱雅公司 用于护理皮肤的套装
CN113194921A (zh) * 2018-12-29 2021-07-30 莱雅公司 用于护理皮肤的套装
FR3111075B1 (fr) * 2020-06-08 2022-12-16 Oreal Composition à base de rétinol
FR3111074B1 (fr) * 2020-06-08 2022-07-01 Oreal Composition à base de rétinol
JP7735334B2 (ja) * 2020-06-30 2025-09-08 ロレアル 安定化レチノールを有する化粧品組成物
WO2022205059A1 (en) * 2021-03-31 2022-10-06 L'oreal Compositions for caring for skin and a package for containing the same

Also Published As

Publication number Publication date
WO2024045049A1 (en) 2024-03-07
CN119654146A (zh) 2025-03-18
FR3139006A1 (fr) 2024-03-01

Similar Documents

Publication Publication Date Title
CN106580798B (zh) 一种全效眼霜及制备方法
KR101868263B1 (ko) 피부 보습용 화장료 조성물
US9248167B2 (en) Exfoliative hair retention-promoting formulation
JP2013028633A (ja) 局所投与用アルギニンヘテロマー
US9468597B1 (en) Stabilized L-ascorbic acid skin serum
EP3203977B1 (de) Dermatologisches kit mit zusammensetzungen auf der basis von hibiskusblüte und buritiöl
CN112691070A (zh) 抗衰组合物、眼霜及其制备方法
KR101418366B1 (ko) 봉독 및 프로폴리스를 함유하는 여드름 예방 또는 치료용 조성물
KR101868481B1 (ko) 눈꽃모양 입자를 형성하는 보습 크림의 화장료 조성물과 이의 제조방법
WO2024045049A1 (en) Composition for caring for keratin materials and mask containing the same
WO2023042911A1 (ja) 腋臭防止用組成物
US9801796B2 (en) Use of parfumery compounds against hair regrowth
JP6651084B1 (ja) ユズ種子及び玄米の抽出物を含有する組成物
KR101221475B1 (ko) 여드름 개선용 화장료 조성물
KR102419399B1 (ko) 시카케어 크림 조성물 및 그 제조방법
KR102523118B1 (ko) 아이소부탄을 유용성분으로 포함하는 헤어케어 조성물
AU2021103390A4 (en) A Skincare Oil
EP2056779A2 (de) Verwendung einer zusammensetzung für die hautbehandlung bei röntgenbestrahlung
JP2020002106A (ja) D−chiro−イノシトールを含む組成物
JP2002524405A (ja) 個体の細胞活性に対するビタミンaの作用を増強するための方法及び組成物、並びにビタミンcの使用
JP2008184395A (ja) 制汗・消臭化粧料およびその製造方法
CN107961201B (zh) 一种爽肤复合物及其应用
CN121943749A (zh) 一种含木棉花提取物的控油舒缓组合物及其用途、化妆品
US20250057784A1 (en) Topical composition for control of demodex
CN119055568A (zh) 一种舒缓组合物及其应用

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20241206

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)